Processa Pharmaceuticals Inc
(PCSA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 3,489 | 3,951 | 2,847 | 2,735 | 3,425 |
| Operating Income | -3,489 | -3,951 | -2,847 | -2,735 | -3,425 |
| Other Income | 52 | 17 | 13 | 6 | 40 |
| Pre-tax Income | -3,437 | -3,934 | -2,834 | -2,729 | -3,385 |
| Net Income Continuous | -3,437 | -3,934 | -2,834 | -2,729 | -3,385 |
| Net Income | $-3,437 | $-3,934 | $-2,834 | $-2,729 | $-3,385 |
| EPS Basic Total Ops | -1.75 | -6.25 | -7.50 | -18.00 | -25.75 |
| EPS Basic Continuous Ops | -1.81 | -6.32 | -7.44 | -18.13 | -25.83 |
| EPS Diluted Total Ops | -1.75 | -6.25 | -7.50 | -18.00 | -25.75 |
| EPS Diluted Continuous Ops | -1.81 | -6.32 | -7.44 | -18.13 | -25.83 |
| EPS Diluted Before Non-Recurring Items | -1.75 | -6.25 | -7.50 | -18.50 | -25.75 |
| EBITDA(a) | $-3,489 | $-3,951 | $-2,847 | $-2,734 | $-3,425 |